Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine the safety and efficacy of an infant formula supplemented with galacto-oligosaccharides (GOS), beta-palmitate and acidified milk in improving the gastrointestinal health and immune response in healthy term infants.


Clinical Trial Description

Infant formulae are the only alternatives to breast milk for infants when, for whatever reason, human milk becomes unavailable.

New-generation infant formulae contain functional ingredients able to mimic some benefits of human milk.

The study formula is supplemented with galacto-oligosaccharides, which favor intestinal positive microflora growth, beta-palmitate, enhancing fat and calcium absorption and softer stool formation, and acidified milk which contributes to immune system maturation.

The aim of this study is to verify the safety of the study formula in healthy term infants and to deepen the efficacy of the functional ingredient blend in term of prebiotic effect, gastrointestinal tolerance and immune response improvement. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Supportive Care


Related Conditions & MeSH terms

  • Formula Feeding of Healthy Full Term Infants

NCT number NCT01197365
Study type Interventional
Source Heinz Italia SpA
Contact
Status Completed
Phase N/A
Start date August 2010
Completion date December 2014

See also
  Status Clinical Trial Phase
Completed NCT03513991 - Evaluation of Different Protein Content of Formulas on Nutrition Status of Infants. N/A
Completed NCT01606683 - Impact of Infant Feeding on Newborn Metabolomic Profile N/A